Correspondence 0000950170-23-008812 from Apexigen, Inc. (CIK 0001814140)
Apexigen, Inc. (CIK 0001814140)
Date: March 20, 2023 · CIK: 0001814140 · Accession: 0000950170-23-008812
AI Filing Summary & Sentiment
File numbers found in text: 333-269912
Letter
March 20, 2023
VIA EDGAR
U.S. Securities and Exchange Commission
Division of Corporation Finance,
100 F Street, N.E.
Washington, D.C. 20549-3628
Attention:
Josh Gorsky and Joe McCann
Re:
Apexigen, Inc. Registration Statement on Form S-1
File No. 333-269912
Acceleration Request
Requested Date: March 21, 2023
Requested Time: 4:05 p.m. Eastern Time,
or as soon thereafter as practicable
Ladies and Gentlemen:
Pursuant to Rule 461 under the Securities Act of 1933, as amended, Apexigen, Inc. (the “Company”) hereby requests that the above-referenced Registration Statement on Form S-1 (File No. 333-269912) (the “Registration Statement”) be declared effective at the “Requested Date” and “Requested Time” set forth above or at such later time as the Company or its counsel may orally request via telephone call to the staff of the Division of Corporation Finance of the Securities and Exchange Commission.
Once the Registration Statement has been declared effective, please orally confirm that event with our counsel, Wilson Sonsini Goodrich & Rosati, Professional Corporation, by calling Lance Brady at (650) 565-3836.
Please direct any questions or comments regarding this acceleration request to Lance Brady at (650) 565-3836.
[Signature page follows]
Sincerely,
Apexigen, Inc.
Show Raw Text
CORRESP
1
filename1.htm
CORRESP
March 20, 2023
VIA EDGAR
U.S. Securities and Exchange Commission
Division of Corporation Finance,
100 F Street, N.E.
Washington, D.C. 20549-3628
Attention:
Josh Gorsky and Joe McCann
Re:
Apexigen, Inc.
Registration Statement on Form S-1
File No. 333-269912
Acceleration Request
Requested Date: March 21, 2023
Requested Time: 4:05 p.m. Eastern Time,
or as soon thereafter as practicable
Ladies and Gentlemen:
Pursuant to Rule 461 under the Securities Act of 1933, as amended, Apexigen, Inc. (the “Company”) hereby requests that the above-referenced Registration Statement on Form S-1 (File No. 333-269912) (the “Registration Statement”) be declared effective at the “Requested Date” and “Requested Time” set forth above or at such later time as the Company or its counsel may orally request via telephone call to the staff of the Division of Corporation Finance of the Securities and Exchange Commission.
Once the Registration Statement has been declared effective, please orally confirm that event with our counsel, Wilson Sonsini Goodrich & Rosati, Professional Corporation, by calling Lance Brady at (650) 565-3836.
Please direct any questions or comments regarding this acceleration request to Lance Brady at (650) 565-3836.
[Signature page follows]
Sincerely,
Apexigen, Inc.
/s/ Xiaodong Yang
Xiaodong Yang, M.D., Ph.D.
Chief Executive Officer
cc:
Francis Sarena, Apexigen, Inc.
Michael E. Coke, Wilson Sonsini Goodrich & Rosati, Professional Corporation
Lance Brady, Wilson Sonsini Goodrich & Rosati, Professional Corporation